VERAPAMIL AND NORVERAPAMIL PLASMA-CONCENTRATIONS DURING LONG-TERM THERAPY IN PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

被引:78
作者
WOODCOCK, BG [1 ]
HOPF, R [1 ]
KALTENBACH, M [1 ]
机构
[1] UNIV FRANKFURT KLINIKUM,ZENTRUM INNEREN MED,KARDIOL ABT,D-6000 FRANKFURT,FED REP GER
关键词
D O I
10.1097/00005344-198001000-00003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:17 / 23
页数:7
相关论文
共 8 条
[1]   PROTEIN-BINDING AND KINETICS OF DRUGS IN LIVER-DISEASES [J].
BLASCHKE, TF .
CLINICAL PHARMACOKINETICS, 1977, 2 (01) :32-44
[2]  
HEGE HG, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1681
[3]   TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY WITH VERAPAMIL, A CALCIUM ANTAGONIST [J].
KALTENBACH, M ;
HOPF, R ;
KELLER, M .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1976, 101 (35) :1284-1287
[4]  
KALTENBACH M, 1979, BRIT HEART J, V42, P35
[5]   METABOLISM OF [C-14]VERAPAMIL [J].
MCILHENNY, HM .
JOURNAL OF MEDICINAL CHEMISTRY, 1971, 14 (12) :1178-+
[7]   PHYSIOLOGICAL DISPOSITION OF VERAPAMIL IN MAN [J].
SCHOMERUS, M ;
SPIEGELHALDER, B ;
STIEREN, B ;
EICHELBAUM, M .
CARDIOVASCULAR RESEARCH, 1976, 10 (05) :605-612
[8]  
SPIEGELHALDER B, 1977, ARZNEIMITTEL-FORSCH, V27, P94